The impact of antidiabetic agents on sarcopenia in type 2 diabetes: a literature review

CN Wu, KJ Tien - Journal of diabetes research, 2020 - Wiley Online Library
Sarcopenia is a geriatric syndrome characterized by decline of skeletal muscle mass and
function. Contributing factors include nutritional, genetic, inflammatory, and endocrinal …

[PDF][PDF] Sarcopenia and chronic complications of type 2 diabetes mellitus

D Purnamasari, EN Tetrasiwi, GJ Kartiko… - Review of Diabetic …, 2022 - ingentaconnect.com
Sarcopenia, defined as the loss of skeletal muscle mass and strength and/or a decrease in
physical performance, is classically related to aging. However, chronic disease, including …

[HTML][HTML] The impact of glucose-lowering drugs on sarcopenia in type 2 diabetes: current evidence and underlying mechanisms

E Massimino, A Izzo, G Riccardi, G Della Pepa - Cells, 2021 - mdpi.com
The age-related decrease in skeletal muscle mass together with the loss of muscle power
and function is defined sarcopenia. Mounting evidence suggests that the prevalence of …

[HTML][HTML] Effects of anti-diabetic drugs on sarcopenia: Best treatment options for elderly patients with type 2 diabetes mellitus and sarcopenia

XY Ma, FQ Chen - World Journal of Clinical Cases, 2021 - ncbi.nlm.nih.gov
Human life expectancy increases as society becomes more developed. This increased life
expectancy poses challenges associated with the rapid aging of the population. Sarcopenia …

Anti‐diabetic drugs and sarcopenia: emerging links, mechanistic insights, and clinical implications

X Zhang, Y Zhao, S Chen… - Journal of cachexia …, 2021 - Wiley Online Library
Sarcopenia, characterized by loss of skeletal muscle mass, quality, and strength, has
become a common hallmark of ageing and many chronic diseases. Diabetes mellitus …

The association between sarcopenia and diabetes: from pathophysiology mechanism to therapeutic strategy

H Chen, X Huang, M Dong, S Wen… - … Syndrome and Obesity, 2023 - Taylor & Francis
Diabetes and sarcopenia are emerging as serious public health issues. Sarcopenia, an age-
related disorder characterized by loss of skeletal muscle mass and function, is recognized …

Diet, exercise, and pharmacotherapy for sarcopenia in people with diabetes

Y Hashimoto, F Takahashi, T Okamura, M Hamaguchi… - Metabolism, 2023 - Elsevier
Diabetes prevalence is increasing rapidly in older people, and sarcopenia is prevalent as a
novel complication, particularly in patients with type 2 diabetes mellitus (T2DM). Therefore …

Sarcopenia and diabetes: pathogenesis and consequences

ME Khamseh, M Malek, R Aghili… - The British Journal of …, 2011 - journals.sagepub.com
Sarcopenia, loss of muscle mass with age, is considered as a major cause of frailty and
decreased independence in the elderly population. On the other hand, ageing is associated …

[HTML][HTML] Sarcopenia and diabetes: hyperglycemia is a risk factor for age-associated muscle mass and functional reduction

H Umegaki - Journal of diabetes investigation, 2015 - ncbi.nlm.nih.gov
Skeletal muscle maintains our posture and produces body movement. Muscle is essential to
make all movements required in daily life. Skeletal muscle has several other roles. It is a …

Sarcopenia and type 2 diabetes mellitus: a bidirectional relationship

J Mesinovic, A Zengin, B De Courten… - … syndrome and obesity …, 2019 - Taylor & Francis
The incidence and prevalence of metabolic and musculoskeletal diseases are increasing.
Type 2 diabetes mellitus (T2DM) is characterized by insulin resistance, inflammation …